HMOX1 and neoplasm: Tumor cells may further resist NK and cytotoxic T lymphocyte-mediated killing by suppressing granzyme and perforin activity or altering pro-/anti-apoptotic gene balance, processes potentially modulated by Nrf2/HO-1.